M&A Deal Summary

Unither Pharmaceuticals Acquires Nanjing Ruinian Best Pharmaceutical Co.

On August 25, 2020, Unither Pharmaceuticals acquired life science company Nanjing Ruinian Best Pharmaceutical Co.

Acquisition Highlights
  • This is Unither Pharmaceuticals’ 2nd transaction in the Life Science sector.
  • This is Unither Pharmaceuticals’ 1st transaction in China.

M&A Deal Summary

Date 2020-08-25
Target Nanjing Ruinian Best Pharmaceutical Co.
Sector Life Science
Buyer(s) Unither Pharmaceuticals
Deal Type Add-on Acquisition

Target

Nanjing Ruinian Best Pharmaceutical Co.

Wuxi, China
Nanjing Ruinian Best Pharmaceutical Co. Ltd. (NRB) specializes in the development and production of solid and liquid form pharmaceutical products.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Unither Pharmaceuticals

Amiens, France

Category Company
Founded 1993
Sector Life Science
Employees1,500
Revenue 330M EUR (2018)
DESCRIPTION

Unither Pharmaceuticals is a developer and manufacturer of pharmaceuticals products. Unither operates six manufacturing sites in France, the United States, and Brazil, and has a dedicated research and development center in Europe. Unither Pharmaceuticals was founded in 1993 and is based in Amiens, France.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
Country: China M&A 1 of 1
Year: 2020 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-17 Mariol Industrial

Barretos, Brazil

Mariol Industrial is a manufacturer that boasts the industrial facilities and expertise necessary to produce solid, semi-solid and liquid suspension dosage forms.

Buy -